SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Zirdu who wrote (4303)5/14/1998 11:48:00 AM
From: Izzy  Respond to of 6136
 
Then you ought to like ADVR, who has developed a peptide nucleic acid drug (Reticulose), which increases the CD4 count and lowers the viral load. Results of a 2+ yr study are being presented 5-21-98 at the American Society of Microbiology in Atlanta. I don't know if you can afford this pricey stock. It's at $0.39 today, up 0.01! What a bargain (another "junk" stock, for now, IMO). I'd rather put my money in more AGPH.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News